Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$640M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$501M |
| 3 |
Digital Realty Trust
DLR
|
+$438M |
| 4 |
Intuitive Surgical
ISRG
|
+$437M |
| 5 |
Amazon
AMZN
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$545M |
| 2 |
DexCom
DXCM
|
+$457M |
| 3 |
AT&T
T
|
+$431M |
| 4 |
Palo Alto Networks
PANW
|
+$416M |
| 5 |
Humana
HUM
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 1.99% |
| 4 | Financials | 1.93% |
| 5 | Industrials | 1.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Amylyx Pharmaceuticals
AMLX
$4.31B
| $17.5M | ﹤0.01% |
813,325
+584,419
| +255% | +$15.8M |
|
1977
Globus Medical
GMED
$11.7B
| $17.5M | ﹤0.01% |
294,532
-834,133
| -74% | -$47.5M |
|
1978
Alexandria Real Estate Equities
ARE
$9.21B
| $17.5M | ﹤0.01% |
154,365
+58,787
| +62% | +$7M |
|
|
IMGN
1979
DELISTED
Immunogen Inc
IMGN
| $17.5M | ﹤0.01% |
928,240
-46,818
| -5% | -$553K |
|
1980
iShares Select Dividend ETF
DVY
$23.9B
| $17.5M | ﹤0.01% |
154,315
+105,893
| +219% | +$12.1M |
|
1981
Urban Outfitters
URBN
$6.36B
| $17.4M | ﹤0.01% |
526,594
+191,539
| +57% | +$5.59M |
|
1982
Hims & Hers Health
HIMS
$7.88B
| $17.4M | ﹤0.01% |
1,855,170
-15,106
| -0.8% | -$150K |
|
1983
PUT
HSBC
HSBC
$357B
| $17.4M | ﹤0.01% |
440,100
-179,700
| -29% | -$6.71M |
|
1984
PUT
Vornado Realty Trust
VNO
$7.07B
| $17.4M | ﹤0.01% |
960,600
+684,700
| +248% | +$10.1M |
|
|
MRTX
1985
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $17.4M | ﹤0.01% |
481,818
+391,174
| +432% | +$16.1M |
|
1986
Azenta
AZTA
$1.64B
| $17.4M | ﹤0.01% |
372,921
+169,334
| +83% | +$7.41M |
|
1987
PUT
ChargePoint
CHPT
$162M
| $17.4M | ﹤0.01% |
98,965
+9,835
| +11% | +$1.72M |
|
1988
Medpace
MEDP
$17.3B
| $17.4M | ﹤0.01% |
72,415
+70,271
| +3,278% | +$14.6M |
|
1989
CALL
EPAM Systems
EPAM
$5.69B
| $17.4M | ﹤0.01% |
77,300
+15,300
| +25% | +$3.85M |
|
1990
NNN REIT
NNN
$8.8B
| $17.3M | ﹤0.01% |
405,345
+344,196
| +563% | +$14.8M |
|
1991
CALL
argenx
ARGX
$65B
| $17.3M | ﹤0.01% |
44,500
+6,300
| +16% | +$2.48M |
|
1992
PUT
Southern Company
SO
$102B
| $17.3M | ﹤0.01% |
246,800
-559,700
| -69% | -$40.1M |
|
1993
Bausch Health
BHC
$2.41B
| $17.3M | ﹤0.01% |
2,166,263
+1,666,151
| +333% | +$12.3M |
|
|
K
1994
DELISTED
Kellanova
K
| $17.3M | ﹤0.01% |
273,800
+252,581
| +1,190% | +$16.1M |
|
1995
CALL
Centene
CNC
$32.1B
| $17.3M | ﹤0.01% |
256,300
-244,600
| -49% | -$16.3M |
|
1996
CALL
RingCentral
RNG
$5.6B
| $17.2M | ﹤0.01% |
526,900
-110,200
| -17% | -$3.39M |
|
1997
Fulgent Genetics
FLGT
$548M
| $17.2M | ﹤0.01% |
464,422
+166,247
| +56% | +$5.79M |
|
1998
PUT
Raymond James Financial
RJF
$33.7B
| $17.2M | ﹤0.01% |
165,700
+135,700
| +452% | +$12.6M |
|
1999
CALL
Western Digital
WDC
$166B
| $17.2M | ﹤0.01% |
598,922
-919,617
| -61% | -$25.6M |
|
2000
CALL
Consolidated Edison
ED
$39.3B
| $17.1M | ﹤0.01% |
189,500
-146,000
| -44% | -$14M |
|
Similar funds
Citadel Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Citadel Advisors held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Citadel Advisors withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in BILL Holdings worth $222M.
- Citadel Advisors's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
- Citadel Advisors added most to Microsoft in Q2 2023, an estimated $640M increase.
- Citadel Advisors's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
- Citadel Advisors fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
- Citadel Advisors's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
- Citadel Advisors opened 1,205 new positions and closed 1,562 in Q2 2023.
- Citadel Advisors's portfolio value rose 6.4% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.